Wall Street is pretty evenly split between the bulls and bears, leaving consensus aligned with Nachman’s cautious take, as TipRanks analytics demonstrate VRX as a Hold. Based on 14 analysts polled by TipRanks in the last 3 months, 4 rate a Buy on Valeant stock, 7 maintain a Hold, while 3 issue a Sell on the stock. The 12-month average price target stands at $19.27, marking a nearly 32% upside from where the stock is currently